Wellnex Life Limited reported a milestone quarter with its first positive operating cash flow of $0.41 million in Q3 FY26, marking a significant turnaround. Customer cash receipts increased by 30.8% to $6.67 million, driven by strong commercial momentum and improved working capital management. Revenue declined by 28.2% to $5.1 million due to reduced IP licensing and lower investment in non-core brands, but the company anticipates stronger revenue growth in Q4 FY26. Structural cost reductions, including a 29% decrease in staff costs and lower advertising and marketing expenses, contributed to the positive cash flow. The Board remains focused on revenue growth, margin improvement, and cash generation in Q4 FY26, with confidence in sustaining the turnaround and strengthening the balance sheet.
| Metric | Q3 FY26 | Q2 FY26 | Change |
|---|---|---|---|
| Customer Cash Receipts ($ million) | 6.67 | 5.10 | +30.8% |
| Operating Cash Flow ($ million) | 0.41 | -0.16 | +57 million (+$0.57 million) |
| Staff Costs ($ million) | 0.75 | 1.06 | -29% |
| Advertising and Marketing Costs ($ million) | 0.54 | 0.62 | -12.9% |
| Revenue - Brands ($ million) | 3.5 | 3.8 | -7.9% |
| Revenue - IP Licensing ($ million) | 1.6 | 3.3 | -51.5% |
| Total Revenue ($ million) | 5.1 | 7.1 | -28.2% |
| Gross Profit ($ million) | 1.5 | 2.1 | -28.6% |
| Debt - Loan Facilities ($ million) | 6.103 | N/A | N/A |
| Debt - Director's Loan ($ million) | 2.525 | N/A | N/A |
| Total Debt ($ million) | 8.628 | N/A | N/A |